Clinical Trial Update: Study of Nitazoxanide Tablets in the Treatment of Mild to Moderate Active Crohn's Disease [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating nitazoxanide tablets for mild to moderate active Crohn's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Nitazoxanide (nitazoxanide)

Snippet

Sponsor: Romark Laboratories L.C. | Conditions: Crohn's Disease | Phase 2 | Status: TERMINATED